336 related articles for article (PubMed ID: 25542987)
1. Preparation and in vitro evaluation of hydrophilic fenretinide nanoparticles.
Ledet GA; Graves RA; Glotser EY; Mandal TK; Bostanian LA
Int J Pharm; 2015 Feb; 479(2):329-37. PubMed ID: 25542987
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.
Graves RA; Ledet GA; Glotser EY; Mitchner DM; Bostanian LA; Mandal TK
Eur J Pharm Sci; 2015 Aug; 76():1-9. PubMed ID: 25933716
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
4. Microencapsulation of amorphous solid dispersions of fenretinide enhances drug solubility and release from PLGA in vitro and in vivo.
Nieto K; Mallery SR; Schwendeman SP
Int J Pharm; 2020 Aug; 586():119475. PubMed ID: 32525080
[TBL] [Abstract][Full Text] [Related]
5. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
[TBL] [Abstract][Full Text] [Related]
6. Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
Wischke C; Zhang Y; Mittal S; Schwendeman SP
Pharm Res; 2010 Oct; 27(10):2063-74. PubMed ID: 20668921
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of nimesulide containing nanocrystal formulations.
Gülsün T; Budak C; Vural I; Sahin S; Öner L
Pharm Dev Technol; 2013; 18(3):653-9. PubMed ID: 22375930
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone solid dispersion system prepared by spray drying method: in vitro and in vivo evaluation.
Pokharkar V; Kutwal M; Mandpe L
PDA J Pharm Sci Technol; 2013; 67(1):23-34. PubMed ID: 23385561
[TBL] [Abstract][Full Text] [Related]
9. Improvement of aqueous solubility of fenretinide and other hydrophobic anti-tumor drugs by complexation with amphiphilic dextrins.
Orienti I; Zuccari G; Carosio R; Montaldo PG
Drug Deliv; 2009 Oct; 16(7):389-98. PubMed ID: 19624248
[TBL] [Abstract][Full Text] [Related]
10. Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables.
Camargo JA; Sapin A; Daloz D; Maincent P
J Microencapsul; 2010; 27(7):609-17. PubMed ID: 20695833
[TBL] [Abstract][Full Text] [Related]
11. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
12. Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.
Ha ES; Choo GH; Baek IH; Kim MS
Molecules; 2014 Dec; 19(12):20325-39. PubMed ID: 25486246
[TBL] [Abstract][Full Text] [Related]
13. Polymer blends used to prepare nifedipine loaded hollow microspheres for a floating-type oral drug delivery system: in vitro evaluation.
Zhao L; Wei YM; Yu Y; Zheng WW
Arch Pharm Res; 2010 Mar; 33(3):443-50. PubMed ID: 20361310
[TBL] [Abstract][Full Text] [Related]
14. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
15. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
Patel GV; Patel VB; Pathak A; Rajput SJ
Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
[TBL] [Abstract][Full Text] [Related]
16. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.
Tran TH; Poudel BK; Marasini N; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Feb; 443(1-2):50-7. PubMed ID: 23318367
[TBL] [Abstract][Full Text] [Related]
18. Fenretinide-polyvinylalcohol conjugates: new systems allowing fenretinide intravenous administration.
Orienti I; Zuccari G; Bergamante V; Carosio R; Gotti R; Cilli M; Montaldo PG
Biomacromolecules; 2007 Oct; 8(10):3258-62. PubMed ID: 17883277
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation.
Allam AN; Hamdallah SI; Abdallah OY
Int J Nanomedicine; 2017; 12():4733-4745. PubMed ID: 28740381
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of betamethasone micro- and nanoparticles using supercritical antisolvent technology: In vitro drug release study and Caco-2 cell cytotoxicity evaluation.
Wang X; He S; Wang K; Wang X; Yan T; Yan T; Wang Z
Eur J Pharm Sci; 2023 Feb; 181():106341. PubMed ID: 36435356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
